MENU

DBMYX BNY Mellon Sm/Md Cp Gr Y Forecast, Technical & Fundamental Analysis

Category MidCapGrowth
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are EQT Corp (NYSE:EQT), Twilio (NYSE:TWLO), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks long-term growth of capital. To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of small-cap and mid-cap U.S. companies. The adviser considers small-cap and mid-cap companies to be those companies with total market capitalizations that are equal to or less than the total market capitalization of the largest company included in the Russell Midcap® Index.

Market Cap

The average market capitalization across the BNY Mellon Sm/Md Cp Gr Y MF is 16.18B. The market cap for tickers in the group ranges from 5.58B to 38.59B. CSGP holds the highest valuation in this group at 38.59B. The lowest valued company is PLNT at 5.58B.

Volume

The average weekly volume growth across all stocks in the BNY Mellon Sm/Md Cp Gr Y MF was 32%. For the same stocks of the MF, the average monthly volume growth was 10% and the average quarterly volume growth was 79%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 86
P/E Growth Rating: 69
Price Growth Rating: 46
SMR Rating: 67
Profit Risk Rating: 56
Seasonality Score: 2 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Fundamentals
Details
Category
Mid-Cap Growth
Address
Dreyfus Investment Funds200 Park AvenueNew York
Phone
1-800-645-6561
Web
https://im.bnymellon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HGTY11.260.38
+3.49%
Hagerty
LIVN53.001.19
+2.30%
LivaNova PLC
NTNX72.240.38
+0.53%
Nutanix
GLSI13.57-0.49
-3.49%
Greenwich LifeSciences
VINC0.34-0.01
-3.52%
Vincerx Pharma

DBMYX and MutualFunds

Correlation & Price change

A.I.dvisor indicates that over the last year, DBMYX has been closely correlated with FSMAX. These tickers have moved in lockstep 97% of the time. This A.I.-generated data suggests there is a high statistical probability that if DBMYX jumps, then FSMAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBMYX
1D Price
Change %
DBMYX100%
-0.51%
FSMAX - DBMYX
97%
Closely correlated
-1.06%
TRQZX - DBMYX
81%
Closely correlated
-0.68%
RPTIX - DBMYX
81%
Closely correlated
-0.68%
PMAQX - DBMYX
79%
Closely correlated
-0.37%
PEMGX - DBMYX
79%
Closely correlated
-0.35%
More